Development Within a Site Development Plan Clause Samples

Development Within a Site Development Plan. The land the subject of the Site development Plan will be developed in accordance with DCP 1 Section 4.16.2 (b), the uses listed in Section 7.4 of the Structure Plan Development Criteria and Section 8 of Master Plan No.14 Detailed Planning Area Plan - (Eastbank / Regatta North) 2001. 12.2.1 Land uses within the Site Development Plan shall be restricted to those specified in the Supplementary Table of Development in Table 1 and to the Development Criteria contained in Section 6.2.1 of this document. 12.2.2 All Development within the Site Development Plan shall be in accordance with Section 11, Implementation of Urban Design Performance Criteria, of this document.
Development Within a Site Development Plan. 4.2.1 The land the subject of the Site Development Plan will be developed in accordance with DCP1 Section 4.16.2 (b), the uses listed in Section 7.4 of the Structure Plan Development Criteria and Section 8 of Master Plan No.14 Detailed Planning Area Plan - (Eastbank / Regatta North) 2001.

Related to Development Within a Site Development Plan

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones) B. Estimated total development time

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Development Phase contractual phase initiated with the approval of ANP for the Development Plan and which is extended during the Production Phase while investments in ▇▇▇▇▇, equipment, and facilities for the Production of Oil and Gas according to the Best Practices of the Oil Industry are required.

  • Program Development NWESD agrees that priority in the development of new applications services by WSIPC shall be in accordance with the expressed direction of the WSIPC Board of Directors operating under their bylaws.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).